IMH.V - Invictus MD Strategies Corp.

TSXV - TSXV Delayed Price. Currency in CAD
1.51
-0.06 (-3.82%)
At close: 4:23PM EST
Stock chart is not supported by your current browser
Previous Close1.57
Open1.59
Bid1.50 x 0
Ask1.51 x 0
Day's Range1.49 - 1.60
52 Week Range0.55 - 2.17
Volume1,535,572
Avg. Volume659,879
Market Cap121.056M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.44
Earnings DateN/A
Forward Dividend & Yield0.32 (35.48%)
Ex-Dividend Date2016-11-17
1y Target EstN/A
  • Invictus MD Provides Update on ACMPR Sales License Amendment as it Prepares for Legalization
    PR Newswire16 days ago

    Invictus MD Provides Update on ACMPR Sales License Amendment as it Prepares for Legalization

    FRA: 8IS1), through its interests in two Access to Cannabis for Medical Purposes Regulations ("ACMPR") license holders, its wholly-owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms") and its one-third interest in AB Laboratories Inc. ("AB Labs"), continues to execute plans that will achieve production capacity of 6,000 kg commencing January 2018, several months before Canada expects cannabis to become recreationally legal. Total current annual production capacity at both locations is approximately 1,500 kg. As announced on October 27, 2017, Health Canada had removed previously disclosed production capacity restrictions at both Acreage Pharms and AB Labs.

  • Invictus MD Provides Update on ACMPR Sales License Amendment as it Prepares for Legalization
    CNW Group16 days ago

    Invictus MD Provides Update on ACMPR Sales License Amendment as it Prepares for Legalization

    Invictus MD Provides Update on ACMPR Sales License Amendment as it Prepares for Legalization

  • PR Newswirelast month

    Invictus MD Strengthens Management Team With Appointment of New CFO

    FRA: 8IS1), is pleased to announce the appointment of Dylan Easterbrook as Chief Financial Officer. Mr. Easterbrook is a seasoned accounting and financial professional, who most recently was controller of a publicly traded global fibre optic connectivity solution provider.  Prior to that role he was with Ernst & Young, one of the largest professional services firms in the world and one of the Big Four accounting firms, where he led audit engagements for both public and privately held companies from a variety of industries, including the emerging markets. Dylan is a Canadian Chartered Professional Accountant (CPA, CA), and also holds a Bachelor of Science in Life Sciences degree from the University of British Columbia.

  • CNW Grouplast month

    Invictus MD Strengthens Management Team With Appointment of New CFO

    Invictus MD Strengthens Management Team With Appointment of New CFO

  • ACCESSWIRElast month

    Today's Research Reports on IntelGenx Technologies, Invictus MD Strategies, Maple Leaf Green World and Zecotek Photonics Inc.

    NEW YORK, NY / ACCESSWIRE / October 30, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group2 months ago

    Invictus MD prepares for legalization with expected cannabis ready production of 6,000 kg

    Invictus MD prepares for legalization with expected cannabis ready production of 6,000 kg

  • PR Newswire2 months ago

    Invictus MD prepares for legalization with expected cannabis ready production of 6,000 kg

    FRA: 8IS1), through its interests in two Access to Cannabis for Medical Purposes Regulations ("ACMPR") license holders, its wholly-owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms") and its one-third interest in AB Laboratories Inc. ("AB Labs"), expects to have production capacity of 6,000 kg commencing January 2018, several months before Canada expects cannabis to become recreationally legal. Total current production capacity at both locations is approximately 1,500 kg. Health Canada has removed the previously disclosed production capacity restrictions at both Acreage Pharms and AB Labs.

  • CNW Group2 months ago

    High Hampton Announces Appointment of Strategic Advisor and CFO

    High Hampton Announces Appointment of Strategic Advisor and CFO

  • PR Newswire2 months ago

    Invictus MD Announces Q2 Year 2017 Results

    FRA: 8IS1) is pleased to announce its financial results for the quarter ended July 31, 2017.  The Company's financial statements for the period are available under the Company's profile on SEDAR at www.sedar.com. All of Invictus MD's existing licensed production facilities under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), its wholly owned subsidiary Acreage Pharms Ltd., located in West-Central Alberta, and its non-wholly owned affiliate AB Laboratories Inc., located near Hamilton, Ontario, are at full production.

  • CNW Group2 months ago

    Invictus MD Announces Q2 Year 2017 Results

    Invictus MD Announces Q2 Year 2017 Results

  • CNW Group3 months ago

    Invictus MD Provides an Update on Construction of Phase 2 at Acreage Pharms Ltd.

    Invictus MD Provides an Update on Construction of Phase 2 at Acreage Pharms Ltd.

  • PR Newswire3 months ago

    Invictus MD Provides an Update on Construction of Phase 2 at Acreage Pharms Ltd.

    FRA: 8IS1) is pleased to announce that construction of the Phase 2 development, a purpose built, multiple room production facility, is well underway at its wholly owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), a licensed producer under the Access to Cannabis for Medical Purposes Regulations ("ACMPR").

  • Marketwired3 months ago

    Invictus MD: Underappreciated Among Licensed Producers - CFN Media

    CFN Media Group , the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Invictus MD Strategies Corp. , its current operations, ...

  • CNW Group4 months ago

    Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.

    Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.

  • PR Newswire4 months ago

    Invictus MD Provides an Update on Harvest by Acreage Pharms Ltd.

    FRA: 8IS) is pleased to announce that its wholly owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), a licensed producer under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), completed its first two successful harvests earlier this month.  Acreage Pharms, utilizing its pesticide free growing systems, anticipates two harvests to take place the first week of September. Trevor Dixon, CEO of Acreage Pharms commented "The yields from both of the first two harvests exceeded expectations. The additional two harvests in the first week of September will utilize the entire grow space which will maximize yields and generate sufficient data to determine anticipated annual production rates.

  • Marketwired5 months ago

    Invictus MD Completes First Harvest & Breaks Ground on Expansion -- CFN Media

    CFN Media Group , the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Invictus MD Strategies Corp.'s progress in building ...

  • CNW Group5 months ago

    Invictus MD's Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update

    Invictus MD's Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update

  • PR Newswire5 months ago

    Invictus MD's Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update

    FRA: 8IS) is pleased to announce that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), Acreage Pharms Ltd. ("Acreage Pharms") located near Edson, Alberta, utilizing a multi-room indoor perpetual growing methodology, will begin its first harvest the first week of August, with the second harvest occurring the following week.  The company anticipates a harvest to take place approximately monthly going forward. Invictus MD is further pleased to announce that Acreage Pharms has received its development permit for Phase 2 and has broken ground initiating construction on its 27,800 square foot purpose built, multiple room production facility. Invictus MD has committed to investing $6.0 million, which will be used to fund the costs of constructing the production facility.

  • PR Newswire5 months ago

    Invictus MD Provides a Corporate Update on AB Laboratories Inc. and AB Ventures Inc.

    FRA: 8IS) is pleased to provide an update that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), AB Laboratories Inc. ("AB Labs") located in Hamilton, Ontario, utilizing a multi-room indoor perpetual growing methodology, completed its first harvest four weeks ago, with the second harvest occurring this week.  The company anticipates a harvest to take place approximately monthly going forward. AB Ventures Inc. ("AB Ventures"), an incorporated company formed to develop a second licensed expansion facility through its common ownership with AB Labs, is forging ahead with planning its Phase 1 expansion which initially includes the development of two 21,000 square foot, multiple room production facilities.  AB Ventures is planning to construct additional production facilities on its 100 acres of land totaling 100,000 square feet.

  • CNW Group5 months ago

    Invictus MD Provides a Corporate Update on AB Laboratories Inc. and AB Ventures Inc.

    Invictus MD Provides a Corporate Update on AB Laboratories Inc. and AB Ventures Inc.

  • PR Newswire6 months ago

    Invictus MD Announces Inclusion on Horizons Marijuana Life Sciences Index ETF

    VANCOUVER , June 23, 2017 /PRNewswire/ -  INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce its inclusion in the ...

  • CNW Group6 months ago

    Invictus MD Announces Inclusion on Horizons Marijuana Life Sciences Index ETF

    Invictus MD Announces Inclusion on Horizons Marijuana Life Sciences Index ETF

  • CNW Group6 months ago

    Invictus MD's Executive Chairman Provides a Corporate Update

    Invictus MD's Executive Chairman Provides a Corporate Update

  • PR Newswire6 months ago

    Invictus MD's Executive Chairman Provides a Corporate Update

    FRA: 8IS) Canada's Cannabis Company, is pleased to provide a corporate update on the back of its recently closed bought deal financing, and reprises its vision to expand and solidify its cultivation portfolio. "Following our successful financing with Canaccord Genuity Corp., Eventus Capital Corp., Echelon Wealth Partners Inc., GMP Securities L.P. and PI Financial Corp., including the over-allotment option, for aggregate gross proceeds of $25,008,750, Invictus MD is well capitalized and prepared for an exciting year of growth," said Dan Kriznic, Executive Chairman, Invictus MD.

  • CNW Group7 months ago

    Invictus MD Closes $25,008,750 Bought Deal Private Placement

    Invictus MD Closes $25,008,750 Bought Deal Private Placement